| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | 11.7 | 1411.3 | 724.3 | 18.0 | - | - | 2165.3 |
| 1 | - | - | - | - | - | 185.0 | 84.7 | 6.0 | - | - | 275.7 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 6 |
| 1 | 2 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 163.7 |
| 1 | 309.7 |
| Number of post synapses: | 6496 |
| Number of pre synapses: | 827 |
| Number of output connections: | 2466 |
| Coverage factor: | 1.6 |
| Columnar completeness: | 0.40 |
| Area completeness: | 0.48 |
| Cell size (columns): | 180 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#MeVP21 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Mi15 (R) | ACh | 1,974 | 658.0 | 30.6% | 30.6% |
| 1 | Cm3 (R) | GABA | 537 | 179.0 | 8.3% | 39.0% |
| 2 | MeTu1 (R) | ACh | 524 | 174.7 | 8.1% | 47.1% |
| 3 | Dm2 (R) | ACh | 495 | 165.0 | 7.7% | 54.8% |
| 4 | Cm9 (R) | Glu | 384 | 128.0 | 6.0% | 60.7% |
| 5 | Cm7 (R) | Glu | 285 | 95.0 | 4.4% | 65.1% |
| 6 | Cm10 (R) | GABA | 235 | 78.3 | 3.6% | 68.8% |
| 7 | MeVPMe11 (L) | Glu | 212 | 70.7 | 3.3% | 72.1% |
| 8 | Tm5c (R) | Glu | 143 | 47.7 | 2.2% | 74.3% |
| 9 | TmY17 (R) | ACh | 133 | 44.3 | 2.1% | 76.4% |
| 10 | Cm12 (R) | GABA | 113 | 37.7 | 1.8% | 78.1% |
| 11 | Cm26 (R) | Glu | 86 | 28.7 | 1.3% | 79.4% |
| 12 | Dm8b (R) | Glu | 73 | 24.3 | 1.1% | 80.6% |
| 13 | Cm20 (R) | GABA | 69 | 23.0 | 1.1% | 81.6% |
| 14 | Cm31a (R) | GABA | 68 | 22.7 | 1.1% | 82.7% |
| 15 | LT58 (R) | Glu | 65 | 21.7 | 1.0% | 83.7% |
| 16 | Dm11 (R) | Glu | 58 | 19.3 | 0.9% | 84.6% |
| 17 | Dm8a (R) | Glu | 58 | 19.3 | 0.9% | 85.5% |
| 18 | Cm8 (R) | GABA | 51 | 17.0 | 0.8% | 86.3% |
| 19 | Tm29 (R) | Glu | 50 | 16.7 | 0.8% | 87.1% |
| 20 | Cm17 (R) | GABA | 48 | 16.0 | 0.7% | 87.8% |
| 21 | MeVP7 (R) | ACh | 41 | 13.7 | 0.6% | 88.5% |
| 22 | MeTu3c (R) | ACh | 30 | 10.0 | 0.5% | 88.9% |
| 23 | MeVC4b (L) | ACh | 30 | 10.0 | 0.5% | 89.4% |
| 24 | Mi10 (R) | ACh | 27 | 9.0 | 0.4% | 89.8% |
| 25 | ME_unclear (R) | ACh | 25 | 8.3 | 0.4% | 90.2% |
| 26 | MeVPMe12 (R) | ACh | 20 | 6.7 | 0.3% | 90.5% |
| 27 | OLVC2 (L) | GABA | 19 | 6.3 | 0.3% | 90.8% |
| 28 | TmY21 (R) | ACh | 19 | 6.3 | 0.3% | 91.1% |
| 29 | Cm15 (R) | GABA | 18 | 6.0 | 0.3% | 91.4% |
| 30 | Cm21 (R) | GABA | 18 | 6.0 | 0.3% | 91.7% |
| 31 | Cm5 (R) | GABA | 17 | 5.7 | 0.3% | 91.9% |
| 32 | Cm_unclear (R) | ACh | 17 | 5.7 | 0.3% | 92.2% |
| 33 | Tm5b (R) | ACh | 17 | 5.7 | 0.3% | 92.4% |
| 34 | Cm34 (R) | Glu | 16 | 5.3 | 0.2% | 92.7% |
| 35 | MeLo4 (R) | ACh | 16 | 5.3 | 0.2% | 92.9% |
| 36 | Tm16 (R) | ACh | 16 | 5.3 | 0.2% | 93.2% |
| 37 | Cm31b (R) | GABA | 14 | 4.7 | 0.2% | 93.4% |
| 38 | Cm29 (R) | GABA | 13 | 4.3 | 0.2% | 93.6% |
| 39 | MeLo1 (R) | ACh | 13 | 4.3 | 0.2% | 93.8% |
| 40 | MeVPMe6 (L) | Glu | 13 | 4.3 | 0.2% | 94.0% |
| 41 | Tm39 (R) | ACh | 13 | 4.3 | 0.2% | 94.2% |
| 42 | Cm2 (R) | ACh | 12 | 4.0 | 0.2% | 94.4% |
| 43 | MeVC7a (L) | ACh | 11 | 3.7 | 0.2% | 94.6% |
| 44 | T2a (R) | ACh | 11 | 3.7 | 0.2% | 94.7% |
| 45 | Cm14 (R) | GABA | 10 | 3.3 | 0.2% | 94.9% |
| 46 | MeLo3b (R) | ACh | 10 | 3.3 | 0.2% | 95.1% |
| 47 | Tm26 (R) | ACh | 10 | 3.3 | 0.2% | 95.2% |
| 48 | Cm6 (R) | GABA | 9 | 3.0 | 0.1% | 95.3% |
| 49 | MeLo14 (R) | Glu | 9 | 3.0 | 0.1% | 95.5% |
| 50 | MeVC9 (L) | ACh | 9 | 3.0 | 0.1% | 95.6% |
| 51 | MeVP8 (R) | ACh | 9 | 3.0 | 0.1% | 95.8% |
| 52 | Cm24 (R) | Glu | 8 | 2.7 | 0.1% | 95.9% |
| 53 | Dm20 (R) | Glu | 8 | 2.7 | 0.1% | 96.0% |
| 54 | Lat1 (R) | unclear | 8 | 2.7 | 0.1% | 96.1% |
| 55 | MeVP42 (R) | ACh | 8 | 2.7 | 0.1% | 96.3% |
| 56 | MeVPMe5 (L) | Glu | 8 | 2.7 | 0.1% | 96.4% |
| 57 | OA-AL2i4 (R) | OA | 8 | 2.7 | 0.1% | 96.5% |
| 58 | Cm11a (R) | ACh | 7 | 2.3 | 0.1% | 96.6% |
| 59 | MeVPaMe2 (L) | Glu | 7 | 2.3 | 0.1% | 96.7% |
| 60 | Tm5Y (R) | ACh | 7 | 2.3 | 0.1% | 96.8% |
| 61 | Cm32 (R) | GABA | 6 | 2.0 | 0.1% | 96.9% |
| 62 | MeTu4f (R) | ACh | 6 | 2.0 | 0.1% | 97.0% |
| 63 | MeVC2 (L) | ACh | 6 | 2.0 | 0.1% | 97.1% |
| 64 | MeVC4a (L) | ACh | 6 | 2.0 | 0.1% | 97.2% |
| 65 | MeVP2 (R) | ACh | 6 | 2.0 | 0.1% | 97.3% |
| 66 | OLVC1 (R) | ACh | 6 | 2.0 | 0.1% | 97.4% |
| 67 | Tm37 (R) | Glu | 6 | 2.0 | 0.1% | 97.5% |
| 68 | 5-HTPMPV03 (R) | 5HT | 5 | 1.7 | 0.1% | 97.6% |
| 69 | Cm1 (R) | ACh | 5 | 1.7 | 0.1% | 97.6% |
| 70 | Cm19 (R) | GABA | 5 | 1.7 | 0.1% | 97.7% |
| 71 | Cm30 (R) | GABA | 5 | 1.7 | 0.1% | 97.8% |
| 72 | MeVP52 (R) | ACh | 5 | 1.7 | 0.1% | 97.9% |
| 73 | Pm9 (R) | GABA | 5 | 1.7 | 0.1% | 98.0% |
| 74 | aMe17a (R) | Glu | 4 | 1.3 | 0.1% | 98.0% |
| 75 | Cm25 (R) | Glu | 4 | 1.3 | 0.1% | 98.1% |
| 76 | Dm4 (R) | Glu | 4 | 1.3 | 0.1% | 98.1% |
| 77 | Dm9 (R) | Glu | 4 | 1.3 | 0.1% | 98.2% |
| 78 | MeTu3b (R) | ACh | 4 | 1.3 | 0.1% | 98.3% |
| 79 | MeVC8 (L) | ACh | 4 | 1.3 | 0.1% | 98.3% |
| 80 | MeVP10 (R) | ACh | 4 | 1.3 | 0.1% | 98.4% |
| 81 | MeVPMe9 (L) | Glu | 4 | 1.3 | 0.1% | 98.4% |
| 82 | OA-AL2i3 (R) | OA | 4 | 1.3 | 0.1% | 98.5% |
| 83 | aMe17b (R) | GABA | 3 | 1.0 | 0.0% | 98.6% |
| 84 | aMe17e (R) | Glu | 3 | 1.0 | 0.0% | 98.6% |
| 85 | aMe5 (R) | ACh | 3 | 1.0 | 0.0% | 98.7% |
| 86 | Cm11c (R) | ACh | 3 | 1.0 | 0.0% | 98.7% |
| 87 | MeVC6 (L) | ACh | 3 | 1.0 | 0.0% | 98.7% |
| 88 | MeVP25 (R) | unclear | 3 | 1.0 | 0.0% | 98.8% |
| 89 | MeVP40 (R) | unclear | 3 | 1.0 | 0.0% | 98.8% |
| 90 | MeVP9 (R) | ACh | 3 | 1.0 | 0.0% | 98.9% |
| 91 | MeVPMe3 (L) | Glu | 3 | 1.0 | 0.0% | 98.9% |
| 92 | Tm20 (R) | ACh | 3 | 1.0 | 0.0% | 99.0% |
| 93 | Tm5a (R) | ACh | 3 | 1.0 | 0.0% | 99.0% |
| instance | NT | total connections | connections /#MeVP21 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | TmY17 (R) | ACh | 453 | 151.0 | 18.2% | 18.2% |
| 1 | Cm31b (R) | GABA | 231 | 77.0 | 9.3% | 27.5% |
| 2 | Tm29 (R) | Glu | 208 | 69.3 | 8.4% | 35.8% |
| 3 | Tm30 (R) | GABA | 170 | 56.7 | 6.8% | 42.6% |
| 4 | Cm31a (R) | GABA | 159 | 53.0 | 6.4% | 49.0% |
| 5 | MeVP52 (R) | ACh | 158 | 52.7 | 6.3% | 55.4% |
| 6 | Tm36 (R) | ACh | 117 | 39.0 | 4.7% | 60.1% |
| 7 | Cm3 (R) | GABA | 84 | 28.0 | 3.4% | 63.4% |
| 8 | MeLo4 (R) | ACh | 81 | 27.0 | 3.3% | 66.7% |
| 9 | Tm37 (R) | Glu | 80 | 26.7 | 3.2% | 69.9% |
| 10 | Tm38 (R) | ACh | 75 | 25.0 | 3.0% | 72.9% |
| 11 | LT58 (R) | Glu | 70 | 23.3 | 2.8% | 75.7% |
| 12 | MeVP47 (R) | unclear | 47 | 15.7 | 1.9% | 77.6% |
| 13 | MeVP36 (R) | unclear | 41 | 13.7 | 1.6% | 79.2% |
| 14 | Tm26 (R) | ACh | 36 | 12.0 | 1.4% | 80.7% |
| 15 | MeVP2 (R) | ACh | 35 | 11.7 | 1.4% | 82.1% |
| 16 | aMe9 (R) | ACh | 29 | 9.7 | 1.2% | 83.3% |
| 17 | MeVPMe7 (R) | Glu | 29 | 9.7 | 1.2% | 84.4% |
| 18 | Cm19 (R) | GABA | 28 | 9.3 | 1.1% | 85.5% |
| 19 | MeVP41 (R) | ACh | 27 | 9.0 | 1.1% | 86.6% |
| 20 | Cm8 (R) | GABA | 25 | 8.3 | 1.0% | 87.6% |
| 21 | Cm15 (R) | GABA | 23 | 7.7 | 0.9% | 88.6% |
| 22 | Cm7 (R) | Glu | 18 | 6.0 | 0.7% | 89.3% |
| 23 | Mi18 (R) | GABA | 18 | 6.0 | 0.7% | 90.0% |
| 24 | Cm9 (R) | Glu | 16 | 5.3 | 0.6% | 90.6% |
| 25 | Tm39 (R) | ACh | 14 | 4.7 | 0.6% | 91.2% |
| 26 | Cm17 (R) | GABA | 13 | 4.3 | 0.5% | 91.7% |
| 27 | Cm21 (R) | GABA | 11 | 3.7 | 0.4% | 92.2% |
| 28 | MeLo3a (R) | ACh | 9 | 3.0 | 0.4% | 92.5% |
| 29 | MeVPMe11 (R) | Glu | 8 | 2.7 | 0.3% | 92.9% |
| 30 | aMe5 (R) | ACh | 6 | 2.0 | 0.2% | 93.1% |
| 31 | Cm5 (R) | GABA | 6 | 2.0 | 0.2% | 93.3% |
| 32 | MeVP59 (R) | ACh | 6 | 2.0 | 0.2% | 93.6% |
| 33 | Cm24 (R) | Glu | 5 | 1.7 | 0.2% | 93.8% |
| 34 | MeVP25 (R) | unclear | 5 | 1.7 | 0.2% | 94.0% |
| 35 | MeVP6 (R) | Glu | 5 | 1.7 | 0.2% | 94.2% |
| 36 | Tm40 (R) | ACh | 5 | 1.7 | 0.2% | 94.4% |
| 37 | Cm10 (R) | GABA | 4 | 1.3 | 0.2% | 94.5% |
| 38 | Dm2 (R) | ACh | 4 | 1.3 | 0.2% | 94.7% |
| 39 | Lawf1 (R) | ACh | 4 | 1.3 | 0.2% | 94.9% |
| 40 | MeTu3c (R) | ACh | 4 | 1.3 | 0.2% | 95.0% |
| 41 | MeVP30 (R) | ACh | 4 | 1.3 | 0.2% | 95.2% |
| 42 | MeVP63 (R) | GABA | 4 | 1.3 | 0.2% | 95.3% |
| 43 | MeVPMe10 (R) | Glu | 4 | 1.3 | 0.2% | 95.5% |
| 44 | Pm8 (R) | GABA | 4 | 1.3 | 0.2% | 95.7% |
| 45 | Tm31 (R) | Glu | 4 | 1.3 | 0.2% | 95.8% |
| 46 | TmY5a (R) | Glu | 4 | 1.3 | 0.2% | 96.0% |
| 47 | Cm23 (R) | Glu | 3 | 1.0 | 0.1% | 96.1% |
| 48 | Cm6 (R) | GABA | 3 | 1.0 | 0.1% | 96.2% |
| 49 | MeTu1 (R) | ACh | 3 | 1.0 | 0.1% | 96.3% |
| 50 | MeVP10 (R) | ACh | 3 | 1.0 | 0.1% | 96.5% |
| 51 | MeVP35 (R) | unclear | 3 | 1.0 | 0.1% | 96.6% |
| 52 | MeVP48 (R) | unclear | 3 | 1.0 | 0.1% | 96.7% |
| 53 | OLVC4 (L) | unclear | 3 | 1.0 | 0.1% | 96.8% |
| 54 | Tm5Y (R) | ACh | 3 | 1.0 | 0.1% | 96.9% |
| 55 | TmY13 (R) | ACh | 3 | 1.0 | 0.1% | 97.1% |